Goetz Kathleen has filed 5 insider transactions across 5 companies since April 2024.
Most recent transaction: a grant/award of 63724 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on May 16, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Goetz Kathleen | Director | A | Director Stock Option (right to buy) | 63724 | $0.00 | 63,724.0000 | 146,194,000 | 9999.99% | 0.04% |
| April 9, 2024 | abrdn Healthcare Opportunities Fund | $THQ | Goetz Kathleen | Director | P | Common Stock | 600 | $19.54 | 1,148.1880 | 0 | 109.45% | 0.00% |
| April 9, 2024 | abrdn Life Sciences Investors | $HQL | Goetz Kathleen | Director | P | Common Stock | 400 | $13.32 | 1,085.3080 | 0 | 58.37% | 0.00% |
| April 9, 2024 | abrdn Healthcare Investors | $HQH | Goetz Kathleen | Director | P | Common Stock | 525 | $16.42 | 1,079.5290 | 0 | 94.67% | 0.00% |
| April 9, 2024 | abrdn World Healthcare Fund | $THW | Goetz Kathleen | Director | P | Common Stock | 200 | $12.53 | 1,017.3770 | 0 | 24.47% | 0.00% |